manufacturers of glp 1 drugs GLP-1 Receptor Agonist Shortage: Challenges and Solutions in Type 2 Diabetes Care The Technologies Propelling GLP-1 Analogues
Description
Improvements in access will take time, and require generation of compelling data (e.g., pharmacoeconomics, impact on comorbidities) and savvy commercial strategy
Exendin-4, a glucagonlike peptide-1 receptor agonist, attenuates breast cancer growth by inhibiting NF-B activation
Bertoccini L, Baroni MG
Madsen had first become interested in this rare form of pancreatic cancer when he was a postdoctoral researcher in Steiner's laboratory at the University of Chicago between 1981 and 1983
[DOI] [PMC free article] [PubMed] [Google Scholar] 99
